Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Net Income Performance
Above historical average.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-69.92M
↑ 36% above average
Average (9y)
$-109.27M
Historical baseline
Range
High:$-57.10M
Low:$-384.10M
CAGR
+1.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-69.92M | +4.0% |
| 2023 | $-72.85M | -4.9% |
| 2022 | $-69.46M | +8.9% |
| 2021 | $-76.25M | -19.6% |
| 2020 | $-63.74M | +58.5% |
| 2019 | $-153.72M | -169.2% |
| 2018 | $-57.10M | +32.3% |
| 2017 | $-84.40M | +78.0% |
| 2016 | $-384.10M | -528.4% |
| 2015 | $-61.12M | - |